{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:05:34Z","timestamp":1779869134331,"version":"3.53.1"},"reference-count":35,"publisher":"Journal of Biomedical Research","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2026]]},"DOI":"10.7555\/jbr.40.20260097","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:02:16Z","timestamp":1779775336000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["&lt;i&gt;Helicobacter pylori&lt;\/i&gt;-induced &lt;i&gt;ADAMDEC1&lt;\/i&gt; overexpression in M2 macrophages drives preneoplastic progression in the gastric mucosa"],"prefix":"10.7555","volume":"40","author":[{"given":"Haoxuan","family":"Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4380","reference":[{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. <i>CA Cancer J Clin<\/i>, 2024, 74(3): 229\u2013263.","DOI":"10.3410\/f.739487650.793592245"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.2","doi-asserted-by":"publisher","unstructured":"Chen Y, Jia K, Xie Y, et al. The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: A comprehensive nationwide cohort analysis[J]. <i>J Hematol Oncol<\/i>, 2025, 18(1): 42.","DOI":"10.1186\/s13045-025-01698-y"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.3","doi-asserted-by":"publisher","unstructured":"Park JY, Georges D, Alberts CJ, et al. Global lifetime estimates of expected and preventable gastric cancers across 185 countries[J]. <i>Nat Med<\/i>, 2025, 31(9): 3020\u20133027.","DOI":"10.1038\/s41591-025-03793-6"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.4","doi-asserted-by":"publisher","unstructured":"Castri F, Ravegnini G, Lodoli C, et al. Gastroblastoma in old age[J]. <i>Histopathology<\/i>, 2019, 75(5): 778\u2013782.","DOI":"10.1111\/his.13951"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.5","doi-asserted-by":"publisher","unstructured":"Petrillo A, Ottaviano M, Pompella L, et al. Rare epithelial gastric cancers: A review of the current treatment knowledge[J]. <i>Ther Adv Med Oncol<\/i>, 2025, 17: 17588359241255628.","DOI":"10.1177\/17588359241255628"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.6","doi-asserted-by":"publisher","unstructured":"Shin J, Park YS. Unusual or uncommon histology of gastric cancer[J]. <i>J Gastric Cancer<\/i>, 2024, 24(1): 69\u201388.","DOI":"10.5230\/jgc.2024.24.e7"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.7","doi-asserted-by":"publisher","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer[J]. <i>Clin Gastroenterol Hepatol<\/i>, 2020, 18(3): 534\u2013542.","DOI":"10.1016\/j.cgh.2019.07.045"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.8","doi-asserted-by":"publisher","unstructured":"Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of <i>Helicobacter pylori<\/i> infection: Systematic review and meta-analysis[J]. <i>Gastroenterology<\/i>, 2017, 153(2): 420\u2013429.","DOI":"10.1053\/j.gastro.2017.04.022"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.9","doi-asserted-by":"publisher","unstructured":"German\u00e0 E, Pepe L, Pizzimenti C, et al. Programmed cell death ligand 1 (PD-L1) immunohistochemical expression in advanced urothelial bladder carcinoma: An updated review with clinical and pathological implications[J]. <i>Int J Mol Sci<\/i>, 2024, 25(12): 6750.","DOI":"10.3390\/ijms25126750"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.10","unstructured":"Correa P. Chronic gastritis: A clinico-pathological classification[J]. <i>Am J Gastroenterol<\/i>, 1988, 83(5): 504\u2013509."},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.11","doi-asserted-by":"publisher","unstructured":"Wroblewski LE, Peek Jr RM, Wilson KT. <i>Helicobacter pylori<\/i> and gastric cancer: Factors that modulate disease risk[J]. <i>Clin Microbiol Rev<\/i>, 2010, 23(4): 713\u2013739.","DOI":"10.1128\/CMR.00011-10"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.12","doi-asserted-by":"publisher","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, et al. <i>Helicobacter pylori<\/i> infection[J]. <i>Nat Rev Dis Primers<\/i>, 2023, 9(1): 19.","DOI":"10.1038\/s41572-023-00431-8"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.13","doi-asserted-by":"publisher","unstructured":"Sorino J, Della Mura M, Ingravallo G, et al. <i>Fusobacterium nucleatum<\/i> and gastric cancer: An emerging connection[J]. <i>Int J Mol Sci<\/i>, 2025, 26(16): 7915.","DOI":"10.3390\/ijms26167915"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.14","doi-asserted-by":"publisher","unstructured":"Xiang M, Li P, Yue X, et al. Dysregulated macrophage immunity in <i>Helicobacter pylori<\/i> infection: Unveiling mechanistic insights and therapeutic implications[J]. <i>Front Immunol<\/i>, 2025, 16: 1636768.","DOI":"10.3389\/fimmu.2025.1636768"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.15","doi-asserted-by":"publisher","unstructured":"Bied M, Ho WW, Ginhoux F, et al. Roles of macrophages in tumor development: A spatiotemporal perspective[J]. <i>Cell Mol Immunol<\/i>, 2023, 20(9): 983\u2013992.","DOI":"10.1038\/s41423-023-01061-6"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.16","doi-asserted-by":"publisher","unstructured":"Xu J, Ding L, Mei J, et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments[J]. <i>Signal Transduct Target Ther<\/i>, 2025, 10(1): 268.","DOI":"10.1038\/s41392-025-02325-5"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.17","doi-asserted-by":"publisher","unstructured":"Chaintreuil P, Kerreneur E, Bourgoin M, et al. The generation, activation, and polarization of monocyte-derived macrophages in human malignancies[J]. <i>Front Immunol<\/i>, 2023, 14: 1178337.","DOI":"10.3389\/fimmu.2023.1178337"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.18","doi-asserted-by":"publisher","unstructured":"Beceiro S, Radin JN, Chatuvedi R, et al. TRPM2 ion channels regulate macrophage polarization and gastric inflammation during <i>Helicobacter pylori<\/i> infection[J]. <i>Mucosal Immunol<\/i>, 2017, 10(2): 493\u2013507.","DOI":"10.1038\/mi.2016.60"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.19","doi-asserted-by":"publisher","unstructured":"Fehlings M, Drobbe L, Moos V, et al. Comparative analysis of the interaction of <i>Helicobacter pylori<\/i> with human dendritic cells, macrophages, and monocytes[J]. <i>Infect Immun<\/i>, 2012, 80(8): 2724\u20132734.","DOI":"10.1128\/IAI.00381-12"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.20","doi-asserted-by":"publisher","unstructured":"O'Shea NR, Chew TS, Dunne J, et al. Critical role of the disintegrin metalloprotease ADAM-like decysin-1 [ADAMDEC1] for intestinal immunity and inflammation[J]. <i>J Crohns Colitis<\/i>, 2016, 10(12): 1417\u20131427.","DOI":"10.1093\/ecco-jcc\/jjw111"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.21","doi-asserted-by":"publisher","unstructured":"Jimenez-Pascual A, Hale JS, Kordowski A, et al. ADAMDEC1 maintains a growth factor signaling loop in cancer stem cells[J]. <i>Cancer Discov<\/i>, 2019, 9(11): 1574\u20131589.","DOI":"10.1158\/2159-8290.CD-18-1308"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.22","doi-asserted-by":"publisher","unstructured":"Jasso GJ, Jaiswal A, Varma M, et al. Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing[J]. <i>PLoS Biol<\/i>, 2022, 20(1): e3001532.","DOI":"10.1371\/journal.pbio.3001532"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.23","doi-asserted-by":"publisher","unstructured":"Pasini FS, Zilberstein B, Snitcovsky I, et al. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma[J]. <i>J Gastroenterol<\/i>, 2014, 49(11): 1453\u20131466.","DOI":"10.1007\/s00535-013-0904-0"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.24","doi-asserted-by":"publisher","unstructured":"Chen R, Jin G, McIntyre TM. The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF[J]. <i>J Biol Chem<\/i>, 2017, 292(24): 10112\u201310122.","DOI":"10.1074\/jbc.M116.771642"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.25","doi-asserted-by":"publisher","unstructured":"Collatuzzo G, Pelucchi C, Negri E, et al. Exploring the interactions between Helicobacter pylori (Hp) infection and other risk factors of gastric cancer: A pooled analysis in the Stomach cancer Pooling (StoP) Project[J]. <i>Int J Cancer<\/i>, 2021, 149(6): 1228\u20131238.","DOI":"10.1002\/ijc.33678"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.26","doi-asserted-by":"publisher","unstructured":"Deng M, Zhang L, Zheng W, et al. <i>Helicobacter pylori<\/i>-induced NAT10 stabilizes MDM2 mRNA <i>via<\/i> RNA acetylation to facilitate gastric cancer progression[J]. <i>J Exp Clin Cancer Res<\/i>, 2023, 42(1): 9.","DOI":"10.1186\/s13046-022-02586-w"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.27","doi-asserted-by":"publisher","unstructured":"Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma[J]. <i>Nat Rev Gastroenterol Hepatol<\/i>, 2022, 19(7): 451\u2013467.","DOI":"10.1038\/s41575-022-00591-0"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.28","doi-asserted-by":"publisher","unstructured":"Chen X, Zou Y, Zhang S, et al. Multi-functional vesicles improve <i>Helicobacter pylori<\/i> eradication by a comprehensive strategy based on complex pathological microenvironment[J]. <i>Acta Pharm Sin B<\/i>, 2022, 12(9): 3498\u20133512.","DOI":"10.1016\/j.apsb.2022.05.014"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.29","doi-asserted-by":"crossref","unstructured":"Satoh-Takayama N, Kato T, Motomura Y, et al. Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA[J]. <i>Immunity<\/i>, 2020, 52(4): 635\u2013649. e4.","DOI":"10.1016\/j.immuni.2020.03.002"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.30","doi-asserted-by":"publisher","unstructured":"Lim MCC, Jantaree P, Naumann M. The conundrum of <i>Helicobacter pylori<\/i>-associated apoptosis in gastric cancer[J]. <i>Trends Cancer<\/i>, 2023, 9(8): 679\u2013690.","DOI":"10.1016\/j.trecan.2023.04.012"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.31","doi-asserted-by":"publisher","unstructured":"Perdiguero EG, Geissmann F. The development and maintenance of resident macrophages[J]. <i>Nat Immunol<\/i>, 2016, 17(1): 2\u20138.","DOI":"10.1038\/ni.3341"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.32","doi-asserted-by":"publisher","unstructured":"Wan C, Deng J, Zhu Y, et al. Targeting tumor-associated macrophages in gastric cancer progression and therapy: Insights from molecular mechanisms to therapeutic applications[J]. <i>Front Pharmacol<\/i>, 2025, 16: 1549694.","DOI":"10.3389\/fphar.2025.1549694"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.33","doi-asserted-by":"publisher","unstructured":"Zhou X, Speer RM, Volk L, et al. Arsenic co-carcinogenesis: Inhibition of DNA repair and interaction with zinc finger proteins[J]. <i>Semin Cancer Biol<\/i>, 2021, 76: 86\u201398.","DOI":"10.1016\/j.semcancer.2021.05.009"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.34","doi-asserted-by":"publisher","unstructured":"Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases[J]. <i>Mol Aspects Med<\/i>, 2008, 29(5): 258\u2013289.","DOI":"10.1016\/b978-0-12-382219-2.00248-9"},{"key":"10.7555\/JBR.40.20260097.swyxyjzzywb.35","doi-asserted-by":"crossref","unstructured":"Diehl NJ, Hibshman PS, Ozkan-Dagliyan I, et al. Targeting the ERK mitogen-activated protein kinase cascade for the treatment of KRAS-mutant pancreatic cancer[J]. <i>Adv Cancer Res<\/i>, 2022, 153: 101\u2013130.","DOI":"10.1016\/bs.acr.2021.07.008"}],"container-title":["Journal of Biomedical Research"],"original-title":[],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:36:58Z","timestamp":1779867418000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.40.20260097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":35,"alternative-id":["JBR-2026-0097"],"URL":"https:\/\/doi.org\/10.7555\/jbr.40.20260097","relation":{},"ISSN":["1674-8301","1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"},{"value":"1674-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}